Literature DB >> 32886537

Definition of Uveitis Refractory to Treatment: A Systematic Review in the Absence of a Consensus.

Rodrigo A Valenzuela1,2, Iván Flores1, Myriam Pujol1, Carolina Llanos3, Ester Carreño4, Gabriel Rada5, Carl P Herbort6,7, Loreto Cuitino1,8, Cristhian A Urzua1,9,10.   

Abstract

PURPOSE: To evaluate the different definition of refractoriness in uveitis in the literature.
METHODS: We systematically searched the literature in order to identify definitions of refractory noninfectious uveitis in adult patients. A search strategy in the databases of MEDLINE and Scopus was used to find articles published between January 2005 and October 2018.
RESULTS: Definitions of corticosteroids-refractoriness were related to two main concepts: persistence of inflammation despite the use of corticosteroid and recurrences above a dosage threshold. In terms of immunomodulatory therapy and biologic agents, we observed a great variety of definitions: persistence of inflammation, number of attacks, side effects or complications, symptoms, and best-corrected visual acuity.
CONCLUSIONS: The results of this systematic review demonstrate the current lack of consensus on the definition for refractory uveitis, regardless of the treatment being used and revealed a new terminology based on a comprehensive and operational definition for each specific category of refractoriness.

Entities:  

Keywords:  Resistant; biologics; consensus; definition; glucocorticoids; immunomodulatory; intractable; refractory; uveitis treatment

Mesh:

Substances:

Year:  2020        PMID: 32886537     DOI: 10.1080/09273948.2020.1793369

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

1.  The efficacy and safety of TNF inhibitor (golimumab) as salvage treatment in patients with refractory noninfectious uveitis.

Authors:  Yi Jin; Shanshan Lu; You Lin; Xiaoyue Mou
Journal:  Inflammopharmacology       Date:  2022-07-08       Impact factor: 5.093

Review 2.  Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis.

Authors:  Ioannis Papasavvas; Ilknur Tugal-Tutkun; Carl P Herbort
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-24

Review 3.  miRNA Landscape in Pathogenesis and Treatment of Vogt-Koyanagi-Harada Disease.

Authors:  Fabian Vega-Tapia; Mario Bustamante; Rodrigo A Valenzuela; Cristhian A Urzua; Loreto Cuitino
Journal:  Front Cell Dev Biol       Date:  2021-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.